More articles from Oncology-Clinical Diagnosis: Neuroendocrine

You have access
Glucagon-like peptide-1 vs. somatostatin receptor targeting in malignant insulinoma
Damian Wild, Martyn Caplin, Emanuel Christ, Helmut Maecke, Peter Ell, Aurel Perren and Jean Reubi

Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 1261;
You have access
Detection of intestinal NET by (68)Ga-DOTATOC PET/multiphase CT
Nils Schreiter, Ingo Steffen, Munenobu Nogami, Ann Mirja Bartels, Vera Froeling, Timm Denecke, Alexander Pöllinger, Ralph Buchert, Winfried Brenner and Rainer Röttgen

Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 1258;
You have access
Somatostatin receptor expression in metastatic NET lesions depends on primary tumor site
Stefan Kaeshammer, Matthias Miederer, C. Fottner, M. Weber and Mathias Schreckenberger

Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 1259;
You have access
Physiological uptake of 68Ga-DOTA-NOC in the head of the pancreas in patients with NET
Paolo Castellucci, Chiara Fuccio, Vincenzo Allegri, Gian Carlo Montini, Valentina Ambrosini, Cristina Nanni, Ivan Santi, Monica Celli, Stefano Boschi and Stefano Fanti

Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 1262;
You have access
Comparison of 18F-FDG PET and 99mTc-TOC scintigraphy in patients with neuroendocrine tumor
Hongli Jing, Fang Li, Zhaohui Zhu and Yanrong Du

Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 1260;
You have access
Somatostatin-receptor PET/CT for in-vivo quantification of receptor density - Correlation with immunohistochemistry using novel monoclonal and polyclonal antibodies
Luisa Goetze, Vikas Prasad, Daniel Kaemmerer, Merten Hommann, Lupp Amelie, Joerg Saenger, Stefan Schulz and Richard Baum

Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 404;
You have access
Comparison of 68Ga-DOTA-NOC and 18F-DOPA PET/CT in patients with neuroendocrine tumours (NETs)
Abhishek Kumar, C. Bal, Sellam Karunanithi, Jaya Shukla, Tushar Mohapatra, Arun Malhotra and Guru Bandopadhyaya

Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 407;
You have access
90Y-DOTATOC therapy in patients with metastatic radioiodine negative differentiated thyroid cancer: Preliminary results
Annibale Versari, Angelina Filice, Andrea Frasoldati, Nadia Cremonini, Mattia Asti, Federica Fioroni, Alessandro Fraternali, Massimiliano Casali and Diana Salvo

Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 403;
You have access
Ga68-DOTANOC uptake in the pancreas: Pathological significance?
Yodphat Krausz, Rina Rubinstein, Eyal Mishani, Marina Orevi, Sagi Tshori, Asher Salmon, Benjamin Glaser, Roland Chisin, David Gross and Nanette Freedman

Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 406;
You have access
A comparison of 68Gallium-DOTA-TOC and 18F-FDG PET/CT in imaging of neuroendocrine tumors (NETs)
Niraj Naswa, C. Bal, Snehlata Lata, Ramamohan Reddy and Arun Malhotra

Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 405;

Main menu

User menu

Search

More articles from Oncology-Clinical Diagnosis: Neuroendocrine

Pages